These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12759129)

  • 41. Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions.
    Guiard BP; El Mansari M; Merali Z; Blier P
    Int J Neuropsychopharmacol; 2008 Aug; 11(5):625-39. PubMed ID: 18205979
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The response of noradrenergic axons to systemically administered DSP-4 in the rat: an immunohistochemical study using antibodies to noradrenaline and dopamine-beta-hydroxylase.
    Fritschy JM; Geffard M; Grzanna R
    J Chem Neuroanat; 1990; 3(4):309-21. PubMed ID: 2204356
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The neurotoxic compound N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride (DSP4) depletes endogenous norepinephrine and enhances release of [3H]norepinephrine from rat cortical slices.
    Landa ME; Rubio MC; Jaim-Etcheverry G
    J Pharmacol Exp Ther; 1984 Oct; 231(1):131-6. PubMed ID: 6491970
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The noradrenergic neurotoxin DSP-4 eliminates the coeruleospinal projection but spares projections of the A5 and A7 groups to the ventral horn of the rat spinal cord.
    Lyons WE; Fritschy JM; Grzanna R
    J Neurosci; 1989 May; 9(5):1481-9. PubMed ID: 2542474
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacological characterization of the norepinephrine and dopamine reuptake inhibitor EB-1020: implications for treatment of attention-deficit hyperactivity disorder.
    Bymaster FP; Golembiowska K; Kowalska M; Choi YK; Tarazi FI
    Synapse; 2012 Jun; 66(6):522-32. PubMed ID: 22298359
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Norepinephrine-mediated suppression of apomorphine-induced aggression and locomotor activity in the rat amygdala.
    Pucilowski O; Trzaskowska E; Kostowski W; Valzelli L
    Pharmacol Biochem Behav; 1987 Feb; 26(2):217-22. PubMed ID: 3575346
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurotoxicity of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride (DSP 4) on noradrenergic neurons is mimicked by its cyclic aziridinium derivative.
    Zieher LM; Jaim-Etcheverry G
    Eur J Pharmacol; 1980 Jul; 65(2-3):249-56. PubMed ID: 7398788
    [No Abstract]   [Full Text] [Related]  

  • 48. Destruction of norepinephrine terminals in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice reduces locomotor activity induced by L-dopa.
    Nishi K; Kondo T; Narabayashi H
    Neurosci Lett; 1991 Feb; 123(2):244-7. PubMed ID: 2027538
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biochemical mapping of the noradrenergic ventral bundle projection sites: evidence for a noradrenergic--dopaminergic interaction.
    O'Donohue TL; Crowley WR; Jacobowitz DM
    Brain Res; 1979 Aug; 172(1):87-100. PubMed ID: 466469
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novelty-oriented behavior in the rat after selective damage of locus coeruleus projections by DSP-4, a new noradrenergic neurotoxin.
    Delini-Stula A; Mogilnicka E; Hunn C; Dooley DJ
    Pharmacol Biochem Behav; 1984 Apr; 20(4):613-8. PubMed ID: 6728877
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intranasal dopamine application increases dopaminergic activity in the neostriatum and nucleus accumbens and enhances motor activity in the open field.
    de Souza Silva MA; Topic B; Huston JP; Mattern C
    Synapse; 2008 Mar; 62(3):176-84. PubMed ID: 18081176
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Depletion of brain norepinephrine with DSP-4 does not alter acquisition or performance of a radial-arm maze task.
    Chrobak JJ; DeHaven DL; Walsh TJ
    Behav Neural Biol; 1985 Jul; 44(1):144-50. PubMed ID: 3834919
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nicotine-stimulated release of [3H]norepinephrine is reduced in the hippocampus of an animal model of attention-deficit/hyperactivity disorder, the spontaneously hypertensive rat.
    Sterley TL; Howells FM; Russell VA
    Brain Res; 2014 Jul; 1572():1-10. PubMed ID: 24833064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective Lifelong Destruction of Brain Monoaminergic Nerves Through Perinatal DSP-4 Treatment.
    Nowak P
    Curr Top Behav Neurosci; 2016; 29():51-71. PubMed ID: 26427851
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity.
    Thomas B; von Coelln R; Mandir AS; Trinkaus DB; Farah MH; Leong Lim K; Calingasan NY; Flint Beal M; Dawson VL; Dawson TM
    Neurobiol Dis; 2007 May; 26(2):312-22. PubMed ID: 17336077
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of cerebral depletion of norepinephrine on conditioned avoidance responding in Sprague-Dawley and Fischer rats.
    Martin GE; Elgin RJ
    Pharmacol Biochem Behav; 1988 May; 30(1):137-42. PubMed ID: 3174736
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: a microdialysis study.
    Lategan AJ; Marien MR; Colpaert FC
    Life Sci; 1992; 50(14):995-9. PubMed ID: 1372673
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neurochemical evidence that cocaine- and amphetamine-regulated transcript (CART) 55-102 peptide modulates the dopaminergic reward system by decreasing the dopamine release in the mouse nucleus accumbens.
    Rakovska A; Baranyi M; Windisch K; Petkova-Kirova P; Gagov H; Kalfin R
    Brain Res Bull; 2017 Sep; 134():246-252. PubMed ID: 28802898
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neurotoxic effects of DSP-4 on the central noradrenergic system in male zebra finches.
    Waterman SA; Harding CF
    Behav Brain Res; 2008 Apr; 188(2):271-80. PubMed ID: 18160108
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cerebellar neurotransmission in attention-deficit/hyperactivity disorder: does dopamine neurotransmission occur in the cerebellar vermis?
    Glaser PE; Surgener SP; Grondin R; Gash CR; Palmer M; Castellanos FX; Gerhardt GA
    J Neurosci Methods; 2006 Feb; 151(1):62-7. PubMed ID: 16451810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.